Page 11 - Society of Nuclear Medicine

Oncology & Cancer

Blood test predicts success of neuroendocrine cancer therapy

Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear ...

Neuroscience

Molecular imaging reveals marker of neurodegenerative disease

Brain researchers have been working for years on targeting a cellular process involved in neurodegeneration and cognitive dysfunction. A specialized molecular imaging agent does the job by binding to a transporter of the ...

page 11 from 28